Xiaoyan Cheng

967 total citations
45 papers, 698 citations indexed

About

Xiaoyan Cheng is a scholar working on Accounting, Strategy and Management and Molecular Biology. According to data from OpenAlex, Xiaoyan Cheng has authored 45 papers receiving a total of 698 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Accounting, 9 papers in Strategy and Management and 7 papers in Molecular Biology. Recurrent topics in Xiaoyan Cheng's work include Auditing, Earnings Management, Governance (17 papers), Corporate Finance and Governance (14 papers) and Pregnancy and preeclampsia studies (6 papers). Xiaoyan Cheng is often cited by papers focused on Auditing, Earnings Management, Governance (17 papers), Corporate Finance and Governance (14 papers) and Pregnancy and preeclampsia studies (6 papers). Xiaoyan Cheng collaborates with scholars based in China, United States and Japan. Xiaoyan Cheng's co-authors include Jing Wang, Bruce D. Smith, David B. Smith, Haibo Li, Yue Li, Paul Tanyi, Meihong Du, Ruixue Zhao, Jingwen Li and Yubao Cui and has published in prestigious journals such as Medicine, Journal of Cellular Biochemistry and Analytical and Bioanalytical Chemistry.

In The Last Decade

Xiaoyan Cheng

43 papers receiving 680 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoyan Cheng China 17 177 151 112 98 76 45 698
Krishna Ramaswamy United States 18 240 1.4× 45 0.3× 96 0.9× 36 0.4× 8 0.1× 33 695
Jie Ding China 12 155 0.9× 77 0.5× 17 0.2× 70 0.7× 120 1.6× 48 591
Hong Bo China 17 302 1.7× 21 0.1× 70 0.6× 19 0.2× 104 1.4× 43 836
Xiaoyang Chen China 15 290 1.6× 180 1.2× 3 0.0× 39 0.4× 107 1.4× 63 814
Marika Vezzoli Italy 15 94 0.5× 18 0.1× 29 0.3× 23 0.2× 6 0.1× 52 706
Muzaffer Eroğlu Türkiye 17 133 0.8× 13 0.1× 8 0.1× 70 0.7× 15 0.2× 73 755
Baomin Chen China 12 88 0.5× 19 0.1× 11 0.1× 28 0.3× 37 0.5× 30 396
Xuemei Liu China 15 117 0.7× 132 0.9× 8 0.1× 176 1.8× 248 3.3× 50 674
David Nugent United Kingdom 17 362 2.0× 200 1.3× 7 0.1× 1.1k 10.8× 128 1.7× 38 1.6k
Hai Huang China 15 547 3.1× 5 0.0× 73 0.7× 41 0.4× 122 1.6× 40 943

Countries citing papers authored by Xiaoyan Cheng

Since Specialization
Citations

This map shows the geographic impact of Xiaoyan Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyan Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyan Cheng more than expected).

Fields of papers citing papers by Xiaoyan Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoyan Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyan Cheng. The network helps show where Xiaoyan Cheng may publish in the future.

Co-authorship network of co-authors of Xiaoyan Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyan Cheng. A scholar is included among the top collaborators of Xiaoyan Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyan Cheng. Xiaoyan Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheng, Xiaoyan, et al.. (2025). Can employee disclosures of future business outlook predict the firm’s cessation as a going concern?. International Journal of Disclosure and Governance. 23(1). 138–155.
2.
Xu, Jiajia, Xiaoyan Cheng, Feng Zhang, et al.. (2024). Artemether Ameliorates Non‐Alcoholic Steatohepatitis by Restraining Cross‐Talk Between Lipotoxicity‐Induced Hepatic Hepatocytes and Macrophages. Phytotherapy Research. 39(2). 604–618. 4 indexed citations
4.
Yang, Yi, Xia Wang, Chunyan Niu, et al.. (2024). Establishment of genomic RNA reference materials for BCR-ABL1 P210 measurement. Analytical and Bioanalytical Chemistry. 416(26). 5733–5742. 1 indexed citations
5.
Cheng, Xiaoyan & Jian‐Ming Ouyang. (2023). Carboxymethylated Rhizoma alismatis Polysaccharides Regulate Calcium Oxalate Crystals Growth and Reduce the Regulated Crystals’ Cytotoxicity. Biomolecules. 13(7). 1044–1044. 5 indexed citations
6.
Yang, Li, et al.. (2022). The tissue factor expression on CD14++CD16-monocytes is a new markers in the Chinese Han older adult population with sepsis: A prospective study. Experimental Gerontology. 171. 112012–112012. 1 indexed citations
7.
Wang, Xia, Yongzhuo Zhang, Chunyan Niu, et al.. (2021). Establishment of primary reference measurement procedures and reference materials for EGFR variant detection in non-small cell lung cancer. Analytical Methods. 13(18). 2114–2123. 10 indexed citations
8.
Tanyi, Paul, David B. Smith, & Xiaoyan Cheng. (2021). Does firm payout policy affect shareholders’ dissatisfaction with directors?. Review of Quantitative Finance and Accounting. 57(1). 279–320. 7 indexed citations
9.
Cheng, Xiaoyan, et al.. (2020). A path analysis investigation of the relationships between CEO pay ratios and firm performance mediated by employee satisfaction. Advances in Accounting. 48. 100457–100457. 26 indexed citations
10.
Ding, Jing, Xiaoyan Cheng, Shuang Liu, et al.. (2019). Apatinib exerts anti-tumour effects on ovarian cancer cells. Gynecologic Oncology. 153(1). 165–174. 23 indexed citations
11.
Li, Jingwen, Qingjun Liu, Yuping Wan, et al.. (2019). Rapid detection of trace Salmonella in milk and chicken by immunomagnetic separation in combination with a chemiluminescence microparticle immunoassay. Analytical and Bioanalytical Chemistry. 411(23). 6067–6080. 44 indexed citations
12.
Wang, Zhe, et al.. (2019). The spleen may be an important target of stem cell therapy for stroke. Journal of Neuroinflammation. 16(1). 20–20. 47 indexed citations
13.
Wang, Jing, et al.. (2019). Assessment efficacy of neutrophil-lymphocyte ratio and monocyte-lymphocyte ratio in preeclampsia. Journal of Reproductive Immunology. 132. 29–34. 56 indexed citations
14.
Wang, Jing, et al.. (2017). siRNA-mediated knockdown of T-bet and RORγt contributes to decreased inflammation in pre-eclampsia. Molecular Medicine Reports. 16(5). 6368–6375. 4 indexed citations
15.
Zhuang, Xun, Qin Wang, Xiaoyan Cheng, et al.. (2017). Liver Dysfunction during Pregnancy and Its Association With Preterm Birth in China: A Prospective Cohort Study. EBioMedicine. 26. 152–156. 31 indexed citations
16.
Cao, Chunyu, Jingyun Li, Jun Li, et al.. (2016). Long Non‐Coding RNA Uc.187 Is Upregulated in Preeclampsia and Modulates Proliferation, Apoptosis, and Invasion of HTR‐8/SVneo Trophoblast Cells. Journal of Cellular Biochemistry. 118(6). 1462–1470. 32 indexed citations
17.
Wang, Jing, et al.. (2015). BRCA2 N372H Polymorphism and Risk of Epithelial Ovarian Cancer. Medicine. 94(42). e1695–e1695. 7 indexed citations
18.
Wang, Jing, et al.. (2015). Vascular endothelial growth factor affects dendritic cell activity in hypertensive disorders of pregnancy. Molecular Medicine Reports. 12(3). 3781–3786. 16 indexed citations
19.
Liu, Yanfeng, Pengcheng He, Lili Shi, et al.. (2014). Prognostic significance of B-cell lymphoma 2 expression in acute leukemia: A systematic review and meta-analysis. Molecular and Clinical Oncology. 2(3). 411–414. 5 indexed citations
20.
Cheng, Xiaoyan, et al.. (2013). SEC Division of Corporation Finance Monitoring and CEO Power. Auditing A Journal of Practice & Theory. 33(1). 29–56. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026